IMMUNE CHECKPOINT INHIBITORS
News & Literature Highlights
March 2021
-
Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries
Circulation
-
Immune Checkpoint Inhibitors
ECG Changes in Melanoma Patients Undergoing Cancer Therapy—Data From the ECoR Registry
Journal of Clinical Medicine
-
Immune Checkpoint Inhibitors
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy
Frontiers in Pharmacology
February 2021
January 2021
-
Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure
Annual Review of Pharmacology and Toxicology
December 2020
November 2020
-
Immune Checkpoint Inhibitors
Cardiotoxicity From Immune Checkpoint Inhibitors
IJC Heart and Vasculature
October 2020
-
Immune Checkpoint Inhibitors
Cardiotoxicity Associated With Immune Checkpoint Inhibitors: A Systemic Review and Meta-Analysis
ASCO Annual Meeting 2020 (Abstract)
September 2020
-
Immune Checkpoint Inhibitors
New Insights Into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
Current Oncology Reports
-
Immune Checkpoint Inhibitors
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
Circulation
-
General Cardio-Oncology
The Role of Biomarkers to Evaluate Cardiotoxicity
Current Treatment Options in Oncology
-
General Cardio-Oncology
Preventing Today’s Survivors of Breast Cancer From Becoming Tomorrow’s Cardiac Patients
JCO Oncology Practice
-
General Cardio-Oncology
Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World
Frontiers in Cardiovascular Medicine
August 2020
July 2020
-
Immune Checkpoint Inhibitors
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor–Related Myocarditis
American Journal of the College of Cardiology
-
Immune Checkpoint Inhibitors
Late Cardiac Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors
Journal for ImmunoTherapy of Cancer
June 2020
May 2020
-
Immune Checkpoint Inhibitors
Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy are at an Increased Risk for Atherosclerotic Cardiovascular Disease
Journal for ImmunoTherapy of Cancer
-
General Cardio-Oncology
Patients With Certain Cancers May Be at a Higher Risk for Atrial Fibrillation
The ASCO Post
-
General Cardio-Oncology
Metabolic Changes May Signal Development of Chemotherapy-Associated Cardiotoxicity
The ASCO Post
-
Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
Journal of the American Heart Association
Meet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
